Health

Launch of VS Wellness on Wheels – Free Cancer Screening Bus

deccanwebtv Jun 19, 2024

Chennai, 19^th June 2024:  The VS Medical Trust, in partnership with the Rotary Club of Madras, proudly announced the successful launch and commencement of medical services of the VS Wellness on Wheels bus today. The launch event was held at the official residence of Thiru Ma. Subramanian, Hon’ble Minister for Health and Family Welfare, Government of Tamil Nadu, marks a significant step towards accessible and comprehensive healthcare for underserved communities.  VS Wellness on Wheels will be used for conducting cancer awareness and screening camps for the underprivileged free of cost.

Thiru Ma. Subramanian inaugurated the event with a heartfelt note, highlighting the critical need for such initiatives. “The VS Wellness on Wheels project is a testament to our collective commitment to enhancing healthcare accessibility and quality for the people of Tamil Nadu. This initiative, spearheaded by VS Medical Trust and supported by the Rotary Club of Madras, embodies the spirit of community and compassion, offering crucial cancer screenings and health services to those who need them the most,” said the Hon’ble Minister.

The launch was attended by eminent personalities, including Prof. Dr. Subramanian, Senior Medical Oncologist, Founder Chairman, and Managing Director of VS Group of Hospitals, Rtn. Ravi Sundaresan, President Rotary Club of Madras, Rotary International District 3232  and other dignitaries from the club, Prof. Dr. S. Sundar, Medical Director and Senior Joint Replacement and Tumour Surgeon at VS Group of Hospitals, Mr. Muthu Subramanian, Executive Director of VS Group of Hospitals and the donors of the bus – Sri. Jain, Founder Chairman, Access Healthcare Sri. EMC Palaniappan, MD, Chona Financial Services Limited and Sri. Vinod Saraogi, Chairman, Go Colors also graced the occasion.

Prof. Dr. Subramanian underscored the escalating crisis of cancer in his address, stating, “With breast and cervical cancers on the rise, early detection is more critical than ever. The VS Wellness on Wheels bus will serve as a mobile health unit, providing life-saving screenings and health services across North Chennai and beyond, especially in areas where healthcare facilities are lacking.”

The VS Wellness on Wheels Bus, equipped with state-of-the-art medical technology, will provide mammograms and other cancer screenings to suburban and rural communities throughout Tamil Nadu. This project aims to offer early diagnosis opportunities and enhance the overall health and well-being of the population.

Rtn Ravi Sundaresan highlighted the importance of this initiative, noting, “The launch of this mobile unit marks the beginning of a new era in healthcare delivery. By bringing advanced medical services directly to the community, we are breaking down barriers to healthcare access and ensuring that even the most remote areas receive the care they deserve.”

He added, “The support from our magnanimous donors and the dedication of the VS Medical Trust and VS Hospitals teams are the driving forces behind this initiative. We are committed to extending the reach of quality healthcare to every corner of Tamil Nadu. We look forward to esteemed corporates, institutions, and industries coming forward to support this wonderful initiative. Including this in your Corporate Social Responsibility (CSR) activities can play a pivotal role in conducting health camps in rural areas in Tamil Nadu and beyond.”

Meril Announces Prestigious LANCET Publication for Landmark RCT of the MYVAL THV Series, Researched and Developed by INDIA

deccanwebtv Jun 19, 2024

~ Meril Life Sciences is proud to announce that its LANDMARK randomized controlled trial (RCT) for the MYVAL THV series has been published in the prestigious medical journal The Lancet ~

~ This recognition underscores the significance and impact of the MYVAL THV series, a pioneering medical device researched and developed entirely in India ~

Chennai, June 19^th, 2024: Meril Life Sciences, an India-based global medical device company, recently conducted a trial study titled ‘Comparison of Early Outcomes of Newer-Generation Myval Transcatheter Heart Valve Series with Contemporary Valves (Sapien and Evolut) THV Series in Real-World Individuals with Severe Symptomatic Native Aortic Stenosis: A Randomised Non-Inferiority Trial’. The LANDMARK randomized controlled trial for the MYVAL THV series has been published in The Lancet, a prestigious medical journal.

Sharing details about the same, Prof. Andreas Baumbach, Global Principal Investigator said, “The Landmark trial showed that the Myval THV series performed as safely and effectively as contemporary THV series. It is a valve made for everyday clinical practice and an all-comers population. The special feature of intermediate diameters allows for more accurate sizing, which has the potential to translate into improved long-term outcomes. Our patients will be followed up for 10 years and it will be interesting to see the long-term results in the three treatment arms.”

This pivotal research compares early outcomes of the new-generation Myval THV series with contemporary (Sapien and Evolut) THV series in real-world patients suffering from severe symptomatic native aortic stenosis (AS). The findings highlight that the Myval THV series is non-inferior to global giants.

On the milestone achievement Interventional cardiologist Dr G.Sengottuvelu,  said, “We are elated and proud at being the first medical device company in India to research and develop MYVAL THV series. Being featured in Lancet underscores the significance and impact of the MYVAL THV series. Also, this has proved India’s capability to set new standards in cardiovascular care, revolutionising heart valve treatment worldwide. This trial also reiterates the success of the ‘Make in India’ initiative.” 

Explaining the importance of THV series, Dr John Jose E, Interventional cardiologist said, The LANDMARK Trial is a well-designed multi-center international study that has established comparable safety and effectiveness of made-in-India Myval trans-catheter heart valve with contemporary western manufactured ones. The results of the study and features of this valve have been well-received by the global interventional Cardiology community. As one of the leading trans-catheter aortic valve implanters’ (TAVI operator) in the country, I am not at all surprised by the results of the study. The study findings align with our clinical experiences in a multinational randomized control trial environment. A considerable number of our Indian patients have surpassed the five-year follow-up mark, and the long-term outcomes appear promising.

The release of this research is a significant milestone, not just for the Indian device sector, but also for the global aortic stenosis patient-population as a whole. The availability of an affordable, safe

and efficacious valve for trans-catheter aortic valve implantation (TAVI- a non-surgical alternative treatment) would greatly benefit patients in emerging nations like India, as well as in advanced countries around the globe.

Dr. Thomas Alexander, Consultant and Interventional Cardiologist and Head of Division of Cardiology at Kovai Medical Center and Hospital, Coimbatore said that MYVAL THV series is a novel THV that comes in various size options compared to currently available THVs, making it easier to find the right fit for different patients.

The Myval THV series is available in a wide range of sizes, including traditional sizes (20 mm, 23 mm, 26 mm, and 29 mm), intermediate sizes (21.5 mm, 24.5 mm, and 27.5 mm), and larger sizes (30.5 mm and 32 mm). This extensive range ensures that more patients receive a valve that closely matches their anatomical needs, potentially improving outcomes and making advanced heart valve treatment more accessible to a broader population.

Watcher Productions presentsCalcutta I’m Sorry

deccanwebtv May 27, 2024

Multiple Sclerosis is a peculiar disease that casts a drastic impact on the spinal cord as well as the brain which affects the individual’s life to a very drastic extent making them totally dependent. Only a few accept the situation and move on…
The Multiple Sclerosis Society of India is doing tremendous service to those affected and spares no effort to create awareness as well as to extend all possible help to those affected!
The much acclaimed feature film, Calcutta, I’m Sorry, scripted and directed by Harry McClure has its theme set around an Anglo – Indian woman named Amanda Wright who serves as a Music Teacher at Conoor is diagnosed with Multiple Sclerosis, much to her shock!
To create awareness about how such persons affected by Multiple Sclerosis moves on and goes on with their lives, MSSI took the initiative of arranging for the screening of the film which was formally flagged off by Ms. Shreya P. Singh, IAS (Exec. Dir., TN Corporation for Development of Women, State Mission Director, National Urban Livelihoods Mission, TN. Govt.), in the presence of Ann Gonsalvez, Honorary Secretary, MSSI and Harry MacLure, the writer/director.
The screenplay describes the long journey of Amanda in a bicycle from Coonor to Chennai (to meet her daughter) and to Calcutta (to meet her granddaughter).
The film is a lesson – learning process as to how one has to face and overcoming challenges in the journey of one’s life!
CREDITS –Written and Wielded by-Harry MacLure
CAST –Priscilla Corner as Amanda, Gillian Pinto as Sabrina & Gillian Williamson as Calcutta Music & Sound Design-Ganesh Ramanna
Cinematography & Editing by-Nicholas Moses

Kauvery Hospital, Radial Road, Launches Kauvery Integrated Stroke Centre – an Advanced and Comprehensive Centre for Stroke and Cerebrovascular Disorders

deccanwebtv May 15, 2024

Stroke, or brain attack, is one of the common causes of disability and death in the world. It is not as uncommon as was previously thought. The World Stroke Organization says that 1 in 4 people will, at some point of time, suffer a stroke. It is, therefore, extremely important that we take cognizance of this highly prevalent problem and do what is necessary to help the society.

A stroke may either occur when the blood vessel to the brain is blocked (Acute Ischaemic Stroke) or when there is bleeding in the brain (Haemorrhagic Stroke). In both these instances, the symptoms are almost the same. It is imperative that the patient reaches a Stroke Centre as soon as possible because with current management protocols, it is possible to reduce or even reverse a stroke. Lives can be saved and disability reduced – but the patient must reach on time. This is because for every second lost, 30,000 brain cells die and for every minute lost, 2 million brain cells die.

The Institute of Brain and Spine at Kauvery Hospital, Radial Road, is happy to announce that within one year since we began treating patients at our hospital, it has been awarded the prestigious Gold Status by the WSO Angels Awards. The hospital, therefore, is ready to go to the next level and has now launched KISC – Kauvery Integrated Stroke Centre. This is an advanced and comprehensive centre for treating stroke and all cerebrovascular disorders under one roof.

“The key words are ‘Advanced’ and ‘Integrated’ – while there may be many Stroke Centres, few have all the different specialties involved working together, in a seamless fashion, in order to ensure that time is saved and the best is done for the patient. Starting from the ER to Radiology to Neurology and Neuro ICU, Neuro Intervention, Neuro OT and finally Neuro Rehabilitation, the Stroke Corridor of KISC ensures a smooth protocol-based management, which has now been acknowledged by the World Stroke Organization. At KISC, we have the technology, the experience and the expertise and, most importantly, the teamwork to achieve the best of results in stroke management,” said Dr Krish Sridhar, Group Mentor, Neurosciences, & Director, Institute of Brain & Spine.

“Every second makes a difference to stroke patients. When they are brought here within the golden hour – 60 minutes – from the onset of stroke symptoms or even within 24 hours, the team at Kauvery Integrated Stroke Centre work relentlessly to reverse stroke and provide optimal outcome for them. As an advanced Stroke Centre, we provide them the best possible chance through international standards of care and a seamless, cohesive and protocol-driven rapid response,” said Dr Anil BG, Medical Director at Kauvery Hospital, Radial Road.

Kauvery Hospital, Radial Road, is a leading healthcare institution offering advanced treatments and surgical interventions in neurology, cardiology, women and child wellness, gastroenterology, orthopaedics, joint reconstruction, urology, nephrology and other specialities. With a dedicated team of experts and state-of-the-art medical facilities including 50+ critical care beds, 20+ NICU beds, 7+ operation theatres, advanced Cath labs, cutting-edge neuro diagnostic equipment like 3T MRI and 4K + 3D neuro microscope, transplant facilities and 24/7 dialysis unit, it provides world-class medical care to patients from around the globe.

சென்னைரேடியல்ரோட்டிலுள்ளகாவேரிமருத்துவமனையில்முதல்சிறுநீரகமாற்றுஅறுவைச்சிகிச்சைவெற்றிகரமாகச்செய்யப்பட்டது

deccanwebtv Mar 29, 2024

மார்ச் 21, 2024, சென்னை: ரேடியல் ரோட்டில் உள்ளகாவேரி மருத்துவமனை தனது முதல் சிறுநீரக மாற்றுஅறுவைச் சிகிச்சையை பிப்ரவரி 21ஆம் தேதி அன்றுவெற்றிகரமாகச் செய்தது. இது, நோயாளிகளின்வாழ்க்கையில் மாற்றம் ஏற்படுத்தும் சிகிச்சைகளைவழங்கும் மருத்துவமனையின் திறன்களில் மற்றொருகுறிப்பிடத்தக்க மைல்கல்லைக் குறிக்கிறது.

நாற்பத்திரண்டு வயதான பெண், இறுதி நிலைசிறுநீரக செயலிழப்பு காரணமாக நான்குஆண்டுகளுக்கும் மேலாக டயாலிசிஸ் செய்து வந்தார். அவர், குடும்ப சிறுநீரக நோயால்பாதிக்கப்பட்டிருந்தார். மேலும், அவரதுசகோதரருக்கு சிறுநீரக மாற்று அறுவைச்சிகிச்சைக்காக அவரது தாய் ஒரு சிறுநீரகத்தைவழங்கியிருந்தார். அவர் குடும்பத்தில் வேறொருதானம் கொடுப்பவர் இல்லாததால், அவர்மருத்துவமனையின் இறந்த நன்கொடையாளர்காத்திருப்புப் பட்டியலில் வைக்கப்பட்டிருந்தார். ரேடியல் ரோட்டில் உள்ள காவேரி மருத்துவமனையில்இறந்தவரின் சிறுநீரகம் நன்கொடையாகவழங்கப்பட்டதன் காரணமாக, நோயாளிக்கு கடந்தமாதம் சிறுநீரக மாற்று அறுவைச் சிகிச்சைசெய்யப்பட்டது.

மருத்துவர் முத்துக்குமார் P, மருத்துவர் கார்த்திகேயன்B, மருத்துவர் ராஜா R, மருத்துவர் பிரதீப்குமார் K, மற்றும் மருத்துவர் முத்து வீரமணி உள்ளிட்டபுகழ்பெற்ற மாற்று அறுவைச் சிகிச்சைமருத்துவர்களும், நிபுணர்களும் கொண்ட குழு, இந்தச் செயல்முறையைச் செய்தது. அறுவைச்சிகிச்சைக்குப் பிறகு, நோயாளி நன்றாகக்குணமடைந்தார் மற்றும் அவரது சிறுநீரக செயல்பாடுதிறம்பட மீட்டெடுக்கப்பட்டது. மருத்துவமனையில்இருந்து வெளியேறிய பிறகு, அவர் தன் அன்றாடநடவடிக்கைகளை சாதாரணமாகச் செய்யும்வலிமையைப் பெற்றிருக்கிறார். இனி அவருக்குடயாலிசிஸ் தேவையில்லை.

மூத்த ஆலோசகரும், சிறுநீரக மருத்துவரும், மாற்றுஅறுவைச் சிகிச்சை நிபுணருமான மருத்துவர்முத்துக்குமார் P, “இங்கு செய்யப்பட்ட எங்கள் முதல்சிறுநீரக மாற்று அறுவைச் சிகிச்சையின் முடிவைக்குறித்து நாங்கள் மிகவும் மகிழ்ச்சியடைகிறோம்.இறந்த நன்கொடையாளரின் குடும்பத்தின்பெருந்தன்மைக்கு நன்றி கூறிக் கொள்கிறோம். தானம் செய்யப்பட்ட சிறுநீரகத்திற்கு நன்றி, அதனால்ஒரு நபருக்கு புதிய வாழ்க்கை கிடைத்துள்ளது. மருத்துவர்கள் குழுவின் அர்ப்பணிப்பு, நிபுணத்துவம், செவிலியர்கள் மற்றும் பிற ஊழியர்களின் ஆதரவைநான் பாராட்ட விரும்புகிறேன். நோயாளி நல்லஆரோக்கியத்தையும், நீண்ட ஆயுளையும் பெறவாழ்த்துகிறேன்” என்றார்.

“இது எங்களின் முதல் சிறுநீரக மாற்று அறுவைச்சிகிச்சை. இறந்த நன்கொடையாளரின் சிறுநீரத்தைநோயாளிக்கு மாற்றும் சிக்கலான இந்த அறுவைச்சிகிச்சையை, மருத்துவமனையில் உள்ள அதிநவீனவசதிகளாலும், சிறந்த மருத்துவர்களின்குழுப்பணியாலும், திறம்பட சிக்கல்கள் இல்லாமல்செய்ய முடிந்தது” என்றார் சிறுநீரகவியலின் மூத்தஆலோசகரான மருத்துவர் ராஜா R.

ரேடியல் ரோட்டில் உள்ள காவேரி மருத்துவமனையில்உள்ள ‘தி இன்ஸ்டிட்யூட் ஆஃப் கிட்னி சயின்சஸ்’, அதிக சவால் மிக்க மாற்று அறுவைச் சிகிச்சை, குழந்தைகளுக்கான மாற்று அறுவைச் சிகிச்சை, ABO-இணக்கமற்ற சிறுநீரக மாற்று அறுவைச்சிகிச்சை மற்றும் கீஹோல்/லேப்ராஸ்கோபிக் டோனர்நெஃப்ரெக்டோமி செயல்முறைகளைச் செய்வதற்கானநிபுணத்துவம் மற்றும் தொழில்நுட்பத்துடன் நன்குபொருத்தப்பட்டுள்ளது.

தனது முதல் சிறுநீரக மாற்று அறுவைச் சிகிச்சையைவெற்றிகரமாக செய்து முடித்த நிலையில், காவேரிமருத்துவமனை, ரேடியல் ரோட்டில், அதிசிறந்தமருத்துவ பராமரிப்பையும் நம்பிக்கையையும்வழங்குவதற்கான தனது பணியைத் தொடர்கிறது.

இது நரம்பியல், இருதயவியல், இரைப்பை குடல், பெண்கள் மற்றும் குழந்தை ஆரோக்கியம், எலும்பியல், மூட்டு புனரமைப்பு, சிறுநீரகவியல், மற்றும் பிற சிறப்புமேம்பட்ட சிகிச்சைகள் மற்றும் அறுவைச் சிகிச்சைமுறைகளை  வழங்கும் ஒரு முன்னணிமருத்துவமனையாகும். அனுபவமிக்க மருத்துவர்கள், 50+ தீவிர சிகிச்சை படுக்கைகள், 20+ பச்சிளம்குழந்தைகளுக்கான படுக்கைகள், 7+ அறுவைசிகிச்சை அறைகள், மேம்பட்ட கேத் லேப்கள், 3T MRI மற்றும் 4K + 3D நியூரோ மைக்ரோஸ்கோப் போன்றகருவிகள் உள்ளிட்ட அதிநவீன மருத்துவவசதிகளுடன், அவசர சிகிச்சை மற்றும்  24/7 டயாலிசிஸ் வசதிகள் கொண்ட மருத்துவமனை ஆகும்.இது உலகம் முழுவதும் உள்ள நோயாளிகளுக்குஉலகத்தரம் வாய்ந்த மருத்துவ சேவையைவழங்குகிறது.

மக்கள் செல்வன் விஜய்சேதுபதியின் வள்ளலார் வேலை வாய்ப்பு சேவை இயக்கம் இணைந்து நடத்திய மருத்துவ முகாம் மற்றும் இரத்ததான முகாம் !!

deccanwebtv Mar 22, 2024

மக்கள் செல்வன் விஜய்சேதுபதி தனது ( VVVSI ) வள்ளலார் வேலை வாய்ப்பு சேவை இயக்கம் மூலம் வேலை வாய்ப்பு, சுயதொழில் வழிகாட்டுதல், கல்வி உதவி, மருத்துவ உதவி, கல்லூரி மாணவர்களுக்கு வாழ்க்கை வழிகாட்டுதல், பேரிடர் உதவிகளை கடந்த 8 ஆண்டுகளாக செய்து வருவது நீங்கள் அறிந்தது. இப்போது மக்கள் செல்வன்
விஜய்சேதுபதியின் மருத்துவ உதவி திட்டத்தின் கீழ் விஜய்சேதுபதியின் வள்ளலார் வேலை வாய்ப்பு சேவை இயக்கம், NURSING STATION HOME NURSING PRIVATE LIMITED மற்றும் AMPHENOL OMNICONNECT INDIA PVT LTD இணைந்து 20-மார்ச் மற்றும் 21- மார்ச் ஆகிய இரண்டு நாட்கள் மருத்துவ முகாம் மற்றும் இரத்ததான முகாம் செங்கல்பட்டு மாவட்டம், மறைமலை நகர்பகுதியில் நடைபெற்றது.

இந்த முகாம் மூலம் 1800 க்கும் மேற்பட்ட நபர்களுக்கு மருத்துவ முகாம் நடத்தப்பட்டது , 200 க்கும் மேற்பட்ட நபர்கள் இரத்த தானம் வழங்கினர்.

மேலும் இந்த முகாமில் சென்னை இந்திராகாந்தி அரசு குழந்தைகள் மருத்துவமனை மற்றும் செங்கல்பட்டு அரசு மருத்துவமனை இரத்த வங்கிகளும் பங்கு பெற்றது , அதன் மூலம் இரத்ததான உதவியானது பொது மக்கள் பயன் பெரும் வகையில் சிறப்பாக நடைபெற்றது.

இந்த முகாமில் பங்கு பெற்று தன்னை இணைத்து கொண்டு குருதி கொடை அளித்த கொடையாளர்கள் , தன்னார்வலர்களுக்கும் & மற்ற உதவியை செய்தவர்களுக்கும் விஜய்சேதுபதியின் வள்ளலார் வேலை வாய்ப்பு சேவை இயக்கம், AMPHENOL OMNICONNECT INDIA PVT LTD மற்றும் NURSING STATION HOME NURSING PRIVATE LIMITED ஆகியோர் இணைந்து நன்றியை தெரிவித்து கொண்டனர்…

Medical Students with Scholarships and Research Grants totaling INR 1.7 Crore.

deccanwebtv Mar 11, 2024

~Almost 60% of scholarship recipients are women~
~6,019 applications received from 603 cities in 29 states of India~

~150+ applications received from Aspirational districts~

India, Chennai, 10^th March 2024: Metropolis Foundation, the CSR arm of India’s leading diagnostic chain, Metropolis Healthcare Limited, hosted the 6th edition of the MedEngage Annual Summit 2024 today in Chennai. As the flagship CSR initiative of Metropolis, MedEngage serves as a holistic medical outreach program that nurtures young medical talent in India. Envisioned by Metropolis Chairman, Dr. Sushil Shah, MedEngage is designed to offer comprehensive guidance, support and direction to emerging healthcare professionals in India.

At this year’s summit, a total of scholarships worth INR 1.7 crorewere awarded to 301 medical students, out of which 29 students were presented with research grants. MedEngage Scholarships were presented to undergraduate and postgraduate medical students across all years of MBBS education, including the postgraduate training years of MD/MS/DNB, alongside the intervening internship year. The scholarships acknowledge outstanding achievements in academic scores, extra-curricular activities, and research papers/thesis presentations.

Key government officials from Tamil Nadu, including Mr. Kumar Jayant, I.A.S., Additional Chief Secretary to the Government, Labour Welfare, and Skill Development Department, and Dr. P. Shanmugapriya, MD., Associate Professor of Microbiology, Nodal Officer (e-Governance) at Directorate of Medical Education and Research, Tamil Nadu, graced the event as Chief Dignitaries. Additionally, medical luminaries from different specialties also participated in the event, contributing to the recognition of the nation’s emerging medical talent.

A key highlight is that 60% of the scholarship recipients are women, emphasizing the program’s commitment to gender diversity and inclusivity in the medical field. Furthermore, in line with the initiative to support government efforts in uplifting aspirational districts, around 60 students were selected from such districts, reflecting the program’s dedication to societal development and equitable access to opportunities. The entire selection process is managed by Deloitte and involves a thorough and competitive procedure for choosing scholarship recipients. Additionally, an eminent jury from the medical fraternity evaluated candidates for research grants, fostering a culture of research and innovation. 

Commenting on the program, Mr. Surendran Chemmenkottil, Chief Executive Officer, Metropolis Healthcare Limited said: “In India, while the demand for healthcare professionals is high, financial constraints and skill gaps hinder many aspiring medical students. Metropolis Foundation’s MEDENGAGE, aims to bridge this gap by providing financial support and opportunities. Our commitment to education and diversity aims to address workforce shortages and create a more inclusive future. By nurturing innovation, we empower the next generation to drive advancements in patient care, improving community health outcomes”.

Dr. Duru Shah, Chairperson, Metropolis Foundation said: “The MedEngage Scholarship program is empowering future healthcare experts and nurturing a healthier, more resilient society for generations to come. It is incredibly gratifying to witness the overwhelming response from young medical students nationwide, with a remarkable 6,019 applications received this year from both government and private medical colleges spanning 603 cities across 29 states. Through this initiative, we are not only enhancing the educational landscape but also providing invaluable support to promising students as they pursue breakthroughs in healthcare research and innovation.” 

Dr. Kirti Chadha, Chief Scientific Officer and Group Head of CSR, Metropolis Healthcare said, “MedEngage embodies our mission at Metropolis: to guide, support, and inspire the future of healthcare. It is the result of our Chairman’s vision and our dedicated CSR efforts. It serves as a beacon of hope for hardworking medical students, reflecting our commitment to addressing their unique needs. By gathering data through surveys and interviews, we tailor our support accordingly. Through digital platforms, we are expanding our reach across the country, aiming to strengthen and inclusively improve healthcare in India.”

The MedEngage scholarship program not only provides financial assistance to deserving students but also facilitates hands-on experience and practical knowledge through Metropolis’ state-of-the-art laboratories nationwide, under expert guidance. Furthermore, MedEngage offers a spectrum of opportunities including Observership Programs, Academic Research Support, Laboratory Tours, Internships, and MedTalk webinars, tailored to enrich the educational journey of our young medical talents. For more information on MedEngage, visit www.med-engage.com.

Kotak Life reinforces its CSR focus on healthcare in Tamil Nadu.

deccanwebtv Mar 8, 2024

Kotak Life reinforces its CSR focus on healthcare in Tamil Nadu, deploys seven Mobile Medical Vans to deliver primary healthcare services
· Over one-third of Kotak Life’s current financial year CSR budget is dedicated to advancing primary healthcare, eye care and kidney care in the state

Chennai, 7 March 2024

Kotak Mahindra Life Insurance Company Limited (Kotak Life) reinforced its commitment to Tamil Nadu’s health care by deploying seven new Mobile Medical Vans (MMV). This strategic initiative aims to enhance primary healthcare services across the state.

Under its Corporate Social Responsibility (CSR) initiative, Kotak Life in collaboration with Smile Foundation will deploy three MMVs in Chennai and two MMVs each in Thoothukudi and Virudhunagar. These MMVs will bring healthcare services to peoples doorsteps, aiding in early identification of health issues. As a part of the initiative, Kotak Life will bear operational expenses, provide medical supplies and ensure the efficient functioning of the MMVs.

Mahesh Balasubramanian, Managing Director, Kotak Mahindra Life Insurance Company Limited said, “Our goal is to make quality healthcare accessible to everyone and this initiative aligns perfectly with our core values of care and service. It aims to make healthcare facilities accessible to underserved sections of society. The initiative contributes to the betterment of national health and supports the United Nations Sustainable Development Goals for Good Health and Well-Being.”

As a part of its corporate social responsibility commitment, Kotak Life for the current financial year has allocated more than a third of total CSR budget to projects in the state of Tamil Nadu. These initiatives primarily concentrate on delivering primary healthcare through MMVs and eye care through eye screening camps. Furthermore, Kotak Life has extended support to hospitals by providing essential medical equipment for eye care and kidney care.